BayWa’s Fate Rests on a Bank Veto as a €2.7 Billion Hole and Legal Onslaught Converge

BayWa faces a make-or-break decision from lenders as debt reduction lags, asset sales falter, and legal investigations intensify over alleged disclosure failures.

The next few weeks will determine whether BayWa can avoid a disorderly collapse. The Munich-based agribusiness group is waiting on a single, binary decision from its core lenders: DZ Bank and HVB must extend a standstill agreement into autumn 2026, or the restructuring plan sealed under Germany’s StaRUG insolvency framework last May will lose its legal foundation. If the banks balk, the entire rescue architecture — built on a targeted €4 billion in debt reduction — collapses.

That target remains a distant ambition. BayWa has secured just €1.3 billion of the planned divestments so far. A fresh €107 million injection from the Cefetra sale will hit the accounts at the end of April, offering temporary breathing room but doing nothing to close the yawning €2.7 billion financing gap at the heart of the restructuring.

Goldman Sachs Mandate Hits a Snag

The next big disposal on the block is the New Zealand fruit subsidiary T&G Global. Goldman Sachs was hired in March 2026 to run a bidding process for BayWa’s 74% stake, with private equity firms Roc Partners and Paine Schwartz among the potential suitors. Analysts estimate the sale could fetch around €300 million — welcome cash, but a drop in the ocean relative to the overall hole.

The process has stalled, however. Hong Kong-based minority shareholder Joy Wing Mau holds just under 20% of T&G and is complicating negotiations. T&G itself has stressed that no final decision has been taken. Even a perfect sale would leave BayWa still needing to find roughly €2.4 billion more from other disposals — and the planned partial sale of its renewable energy division fell through after the US scrapped key subsidies.

Legal Front Heats Up on Multiple Sides

While the balance sheet crisis plays out, the legal pressure is mounting. The Tübingen law firm TILP is preparing damages claims for shareholders who bought BayWa shares between January 2022 and January 2026. The basis is a BaFin censure finding that the company’s 2023 management report omitted material details about a billion-euro loan and refinancing risks tied to a €500 million bond. TILP argues this constituted deception over price-sensitive facts, opening liability for the company and former board members.

The auditor is also in the crosshairs. PricewaterhouseCoopers issued an unqualified audit opinion for 2023 without flagging existential risks. The audit oversight body Apas has opened professional disciplinary proceedings against PwC. BayWa is tendering the audit mandate from 2026 and is examining its own claims against the former auditors.

Separately, the Munich I public prosecutor’s office is investigating former CEOs Klaus Josef Lutz and Marcus Pöllinger for breach of trust and false presentation in the 2023 annual accounts. Police raids took place in January. All suspects are presumed innocent.

Internal Controls Tighten as the Board Shrinks

The supervisory board is responding with stricter oversight. Monika Hohlmeier and Michael Höllerer resigned at the end of March, and Monique Surges will follow at the end of May. The threshold for transactions requiring board approval has been slashed from €200 million to €50 million.

Operationally, management has scrapped its 2026 guidance. The adjusted EBITDA target for 2027 stands at around €140 million. By 2028, the plan is to shrink the former €24 billion conglomerate into a focused agricultural and construction materials trader with roughly €10 billion in revenue — a process that will eliminate about 1,300 jobs.

Bank Exposure and the Ultimate Test

The cooperative banks of Bavaria carry the restructuring risk on both sides of the balance sheet — as shareholders and lenders. At the annual press conference of the Genossenschaftsverband Bayern, president Stefan Müller acknowledged that primary banks had been advised to take further writedowns, potentially including a complete write-off of promissory note loans worth hundreds of millions of euros.

The stock trades at €14.35, down roughly 14% since the start of the year. The decision from DZ Bank and HVB on the standstill extension is expected in the coming weeks and will set the next major price catalyst. Investors will also have to wait for hard data on current conditions: the audited consolidated accounts for 2025 are not expected until the fourth quarter of 2026.